Biomarin Pharmaceutical (BM8.STU) Q2 2026 Earnings

4MayConfirmed
Q2 2026
0.59
0.61
0.63
0.65

Details

Expected EPS
0.59196432755
Actual EPS
0.6500356
Surprise EPS
0.06
Surprise Percent
+9.81%

Description

Biomarin Pharmaceutical (BM8.STU) has reported earnings of 0.6500356 per share for Q2 2026.

0 Comments

Share your thoughts